16 Oct

UNH Stock Up 4.1% on Solid Q3 2018 Results, View Up

WRITTEN BY Sarah Collins

UnitedHealth Group reports its Q3 2018 earnings results

Today, UnitedHealth Group (UNH) released its third-quarter earnings. The company reported sales of $56.6 billion, up ~12.4% on a YoY (year-over-year) basis. The company’s sales for the quarter exceeded Wall Street’s estimate of $56.3 billion.

UNH’s third-quarter adjusted EPS reached $3.41, ahead of Wall Street’s estimate of $3.29. The company’s adjusted EPS represented YoY growth of ~28.2%. UnitedHealth Group’s earnings from operations rose ~12.3% to $4.6 billion.

The company reported strong growth in its cash flow from operations, rising to $4.6 billion from $4.1 billion in the third quarter of 2017. Today, UNH stock rose ~3.7% in premarket trading. During the day, the stock was up ~4.1%.

UNH Stock Up 4.1% on Solid Q3 2018 Results, View Up

UNH’s medical care ratio slipped

In the third quarter, UnitedHealth Group’s (UNH) consolidated medical care ratio was 81.0%, representing a YoY decrease of 40 basis points. On a sequential basis, the company’s medical care ratio declined from 81.9% in the second quarter.

The major factors impacting UNH’s third-quarter medical care ratio included the return of the health insurance tax, which was more than offset by the business mix changes and operational efficiencies. A health insurance company’s medical care ratio comprises the medical costs incurred as a percentage of premium revenues.

Segment performance

In the third quarter, UnitedHealth Group’s UnitedHealthcare business registered year-over-year sales growth of ~12.8% to $45.9 billion. This segment’s performance was driven by an increase in the consumer base, a pricing increase, the health insurance tax resumption, and its sales membership mix.

The UnitedHealthcare business reported earnings from operations of $2.6 billion, up ~7.0% year-over-year. However, its third-quarter operating margin declined by 30 basis points YoY to 5.6%, as its government program unit generated higher growth.

UnitedHealth Group’s Optum business reported third-quarter sales of $25.4 billion, up ~11.0% year-over-year. OptumHealth, OptumInsight, and OptumRx posted YoY sales growth of 15.2%, 12.5%, and 9.3%, respectively. The segment’s third-quarter operating margin expanded by 60 basis points.

UNH raised its earnings guidance for fiscal 2018

During its third-quarter earnings announcement, UNH raised its fiscal 2018 guidance. The company’s adjusted EPS for fiscal 2018 is expected to be ~$12.80, up from its previous guidance range of $12.50–$12.75.

Among UnitedHealth Group’s peers, Aetna (AET), Cigna (CI), and Anthem (ANTM) are expected to report sales growth of 2.0%, 8.8%, and 3.8%, respectively.

Check out all the data we’ve added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!

Latest articles

Tortoise Capital Advisors bought 9.5 million Kinder Morgan shares in Q3. That was the biggest addition among the company’s top 10 institutional investors.

Although near-term weakness exists in the cannabis stocks, we expect Cannabis 2.0 products or cannabis-derived products could act as a catalyst.

The US, Saudi Arabia, and Russia are the world’s top three crude oil producers. Let’s take a look at the world’s top oil players by production volumes.

Tesla’s Model Y is gearing up to enter the EV market next summer. Ford heated up this space with its announcement of the Mustang Mach-E launch in late 2020.

Yesterday, Comcast (CMCSA) rose 0.5% and closed at $44.81, with a market capitalization of $203.9 billion. But can you expect a further rise?

Advanced Micro Devices (AMD) is one of the best-performing semiconductor stocks of 2019, beating 100% year-to-date growth.